Cerebellar Neoplasms

"Cerebellar Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Primary or metastatic neoplasms of the CEREBELLUM. Tumors in this location frequently present with ATAXIA or signs of INTRACRANIAL HYPERTENSION due to obstruction of the fourth ventricle. Common primary cerebellar tumors include fibrillary ASTROCYTOMA and cerebellar HEMANGIOBLASTOMA. The cerebellum is a relatively common site for tumor metastases from the lung, breast, and other distant organs. (From Okazaki & Scheithauer, Atlas of Neuropathology, 1988, p86 and p141)

Descriptor ID	D002528
MeSH Number(s)	C04.588.614.250.195.411.211 C10.228.140.211.500.200 C10.228.140.252.200 C10.551.240.250.400.300
Concept/Terms	Cerebellar Neoplasms Cerebellar Neoplasms Cerebellar Tumors Cerebellar Tumor Tumor, Cerebellar Neoplasms, Cerebellar Cerebellar Neoplasm Neoplasm, Cerebellar Cerebellar Neoplasms, Primary Cerebellar Neoplasms, Primary Cerebellar Neoplasm, Primary Primary Cerebellar Neoplasm Primary Cerebellar Neoplasms Primary Neoplasms, Cerebellum Cerebellum Primary Neoplasm Cerebellum Primary Neoplasms Neoplasm, Cerebellum Primary Primary Neoplasm, Cerebellum Neoplasms, Cerebellar, Primary Benign Cerebellar Neoplasms Benign Cerebellar Neoplasms Benign Cerebellar Neoplasm Cerebellar Neoplasm, Benign Neoplasm, Benign Cerebellar Neoplasms, Cerebellar, Benign Cerebellar Neoplasms, Benign Cerebellar Cancer Cerebellar Cancer Cancer, Cerebellar Cerebellar Cancers Cerebellar Neoplasms, Malignant Neoplasms, Cerebellar, Malignant Malignant Cerebellar Neoplasms Cerebellar Neoplasm, Malignant Malignant Cerebellar Neoplasm Neoplasm, Malignant Cerebellar

Below are MeSH descriptors whose meaning is more general than "Cerebellar Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Nervous System Neoplasms [C04.588.614]
Central Nervous System Neoplasms [C04.588.614.250]
Brain Neoplasms [C04.588.614.250.195]
Infratentorial Neoplasms [C04.588.614.250.195.411]
Cerebellar Neoplasms [C04.588.614.250.195.411.211]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Brain Neoplasms [C10.228.140.211]
Infratentorial Neoplasms [C10.228.140.211.500]
Cerebellar Neoplasms [C10.228.140.211.500.200]
Cerebellar Diseases [C10.228.140.252]
Cerebellar Neoplasms [C10.228.140.252.200]
Nervous System Neoplasms [C10.551]
Central Nervous System Neoplasms [C10.551.240]
Brain Neoplasms [C10.551.240.250]
Infratentorial Neoplasms [C10.551.240.250.400]
Cerebellar Neoplasms [C10.551.240.250.400.300]

Below are MeSH descriptors whose meaning is related to "Cerebellar Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Cerebellar Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cerebellar Neoplasms" by people in this website by year, and whether "Cerebellar Neoplasms" was a major or minor topic of these publications.

Bar chart showing 39 publications over 25 distinct years, with a maximum of 3 publications in 2002 and 2006 and 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	1	0	1
1998	2	0	2
1999	1	0	1
2000	2	0	2
2002	3	0	3
2003	2	0	2
2004	1	0	1
2005	0	1	1
2006	3	0	3
2008	1	0	1
2009	1	0	1
2010	1	0	1
2011	1	0	1
2012	2	0	2
2013	2	0	2
2014	1	1	2
2015	0	1	1
2016	1	0	1
2017	0	1	1
2018	0	1	1
2020	2	0	2
2021	1	0	1
2023	3	0	3
2024	2	0	2

Below are the most recent publications written about "Cerebellar Neoplasms" by people in Profiles.

Wang T, Liu L, Rampisela D, Dong X, Keith KA, Benardete EA, Shan FY. A Cerebellar Tumor-to-Tumor Metastasis in a Patient With Von Hippel-Lindau Disease. Appl Immunohistochem Mol Morphol. 2024 May-Jun 01; 32(5):244-248.

View in: PubMed
Green S, Hoover T, Doss D, Davidow K, Walter AW, Cottrell CE, Mahapatra S. WNT-activated, MYC-amplified medulloblastoma displaying intratumoural heterogeneity. Neuropathol Appl Neurobiol. 2024 02; 50(1):e12945.

View in: PubMed
Chapman OS, Luebeck J, Sridhar S, Wong IT, Dixit D, Wang S, Prasad G, Rajkumar U, Pagadala MS, Larson JD, He BJ, Hung KL, Lange JT, Dehkordi SR, Chandran S, Adam M, Morgan L, Wani S, Tiwari A, Guccione C, Lin Y, Dutta A, Lo YY, Juarez E, Robinson JT, Korshunov A, Michaels JA, Cho YJ, Malicki DM, Coufal NG, Levy ML, Hobbs C, Scheuermann RH, Crawford JR, Pomeroy SL, Rich JN, Zhang X, Chang HY, Dixon JR, Bagchi A, Deshpande AJ, Carter H, Fraenkel E, Mischel PS, Wechsler-Reya RJ, Bafna V, Mesirov JP, Chavez L. Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma. Nat Genet. 2023 12; 55(12):2189-2199.

View in: PubMed
Poiset SJ, Reddy A, Tucker CM, Kenyon LC, Judy KD, Shi W. Hemangioblastoma with late leptomeningeal metastasis: a case report. J Med Case Rep. 2023 Mar 20; 17(1):102.

View in: PubMed
Katsushima K, Pokhrel R, Mahmud I, Yuan M, Murad R, Baral P, Zhou R, Chapagain P, Garrett T, Stapleton S, Jallo G, Bettegowda C, Raabe E, Wechsler-Reya RJ, Eberhart CG, Perera RJ. The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas. Acta Neuropathol Commun. 2023 03 10; 11(1):38.

View in: PubMed
Kumar R, Smith KS, Deng M, Terhune C, Robinson GW, Orr BA, Liu APY, Lin T, Billups CA, Chintagumpala M, Bowers DC, Hassall TE, Hansford JR, Khuong-Quang DA, Crawford JR, Bendel AE, Gururangan S, Schroeder K, Bouffet E, Bartels U, Fisher MJ, Cohn R, Partap S, Kellie SJ, McCowage G, Paulino AC, Rutkowski S, Fleischhack G, Dhall G, Klesse LJ, Leary S, Nazarian J, Kool M, Wesseling P, Ryzhova M, Zheludkova O, Golanov AV, McLendon RE, Packer RJ, Dunham C, Hukin J, Fouladi M, Faria CC, Pimentel J, Walter AW, Jabado N, Cho YJ, Perreault S, Croul SE, Zapotocky M, Hawkins C, Tabori U, Taylor MD, Pfister SM, Klimo P, Boop FA, Ellison DW, Merchant TE, Onar-Thomas A, Korshunov A, Jones DTW, Gajjar A, Ramaswamy V, Northcott PA. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. J Clin Oncol. 2021 03 01; 39(7):807-821.

View in: PubMed
Dhall G, O'Neil SH, Ji L, Haley K, Whitaker AM, Nelson MD, Gilles F, Gardner SL, Allen JC, Cornelius AS, Pradhan K, Garvin JH, Olshefski RS, Hukin J, Comito M, Goldman S, Atlas MP, Walter AW, Sands S, Sposto R, Finlay JL. Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial. Neuro Oncol. 2020 12 18; 22(12):1862-1872.

View in: PubMed
Cheng Y, Liao S, Xu G, Hu J, Guo D, Du F, Contreras A, Cai KQ, Peri S, Wang Y, Corney DC, Noronha AM, Chau LQ, Zhou G, Wiest DL, Bellacosa A, Wechsler-Reya RJ, Zhao Y, Yang ZJ. NeuroD1 Dictates Tumor Cell Differentiation in Medulloblastoma. Cell Rep. 2020 06 23; 31(12):107782.

View in: PubMed
Davidow KA, Walter AW. Medulloblastoma and secondary acute myeloid leukemia in a patient with Turner syndrome. Pediatr Blood Cancer. 2019 04; 66(4):e27576.

View in: PubMed
Denysenko L, Sagot A. Post-surgical cerebellar mutism and catatonia. Acta Neurochir (Wien). 2017 07; 159(7):1253-1254.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement